X-134781846-C-T

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001387468.1(PABIR2):​c.634G>A​(p.Ala212Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000128 in 1,197,558 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 86 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A212V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000045 ( 0 hom., 5 hem., cov: 23)
Exomes 𝑓: 0.00014 ( 0 hom. 81 hem. )

Consequence

PABIR2
NM_001387468.1 missense

Scores

17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.0950

Publications

0 publications found
Variant links:
Genes affected
PABIR2 (HGNC:30490): (PABIR family member 2) Predicted to enable protein serine/threonine phosphatase inhibitor activity. Predicted to be involved in negative regulation of catalytic activity. Predicted to be part of collagen trimer. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0043709576).
BS2
High Hemizygotes in GnomAd4 at 5 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PABIR2NM_001387468.1 linkc.634G>A p.Ala212Thr missense_variant Exon 9 of 10 ENST00000343004.10 NP_001374397.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PABIR2ENST00000343004.10 linkc.634G>A p.Ala212Thr missense_variant Exon 9 of 10 1 NM_001387468.1 ENSP00000339207.6 G1UD79

Frequencies

GnomAD3 genomes
AF:
0.0000539
AC:
6
AN:
111242
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00227
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000270
AC:
48
AN:
177872
AF XY:
0.000415
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000531
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000745
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000228
GnomAD4 exome
AF:
0.000136
AC:
148
AN:
1086265
Hom.:
0
Cov.:
27
AF XY:
0.000229
AC XY:
81
AN XY:
354083
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26233
American (AMR)
AF:
0.000518
AC:
18
AN:
34765
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19110
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30039
South Asian (SAS)
AF:
0.00213
AC:
111
AN:
52173
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39544
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4086
European-Non Finnish (NFE)
AF:
0.0000168
AC:
14
AN:
834728
Other (OTH)
AF:
0.000110
AC:
5
AN:
45587
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.427
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000449
AC:
5
AN:
111293
Hom.:
0
Cov.:
23
AF XY:
0.000149
AC XY:
5
AN XY:
33503
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30700
American (AMR)
AF:
0.00
AC:
0
AN:
10386
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2644
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3581
South Asian (SAS)
AF:
0.00190
AC:
5
AN:
2629
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5887
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53051
Other (OTH)
AF:
0.00
AC:
0
AN:
1513

Age Distribution

Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000368
Hom.:
0
Bravo
AF:
0.0000340
ExAC
AF:
0.000371
AC:
45

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 16, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.631G>A (p.A211T) alteration is located in exon 9 (coding exon 9) of the FAM122B gene. This alteration results from a G to A substitution at nucleotide position 631, causing the alanine (A) at amino acid position 211 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.80
T
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.011
DANN
Benign
0.59
DEOGEN2
Benign
0.070
T;T;.;.;.;T
FATHMM_MKL
Benign
0.041
N
LIST_S2
Benign
0.82
T;T;T;T;T;.
M_CAP
Benign
0.013
T
MetaRNN
Benign
0.0044
T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.0
L;.;.;.;.;.
PhyloP100
-0.095
PrimateAI
Benign
0.29
T
PROVEAN
Benign
0.13
N;.;N;N;.;.
REVEL
Benign
0.047
Sift
Benign
0.43
T;.;T;T;.;.
Sift4G
Benign
0.66
T;T;T;T;T;T
Polyphen
0.019
B;.;.;B;B;.
Vest4
0.088
MutPred
0.065
Gain of relative solvent accessibility (P = 0.0215);.;.;.;.;.;
MVP
0.20
MPC
0.61
ClinPred
0.0060
T
GERP RS
-1.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.036
gMVP
0.19
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs757171918; hg19: chrX-133915876; API